Glioma therapies: How to tell which work?

被引：18

作者：

Perry, JR

Cairncross, JG

机构：

[1] Univ Toronto, Dept Med, Sunnybrook & Womens Hlth Sci Ctr, Toronto, ON, Canada

[2] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada

[3] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada

[4] Tom Baker Canc Clin, Calgary, AB, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 19期

关键词：

D O I：

10.1200/JCO.2003.05.885

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3547 / 3549

页数：3

共 10 条

[1] Influence of unrecognized molecular heterogeneity on randomized clinical trials [J].

Betensky, RA ;

Louis, DN ;

Cairncross, JG .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2495-2499

[2]

CAIRNCROSS JG, 1985, ANN NEUROL, V17, P570

[3] Phase I and II trials of novel anti-cancer agents: Endpoints, efficacy and existentialism - The Michel Clavel lecture, held at the 10th NCI-EORTC Conference on New Drugs in Cancer Therapy, Amsterdam, 16-19 June 1998 [J].

Eisenhauer, EA .

ANNALS OF ONCOLOGY, 1998, 9 (10) :1047-1052

[4] Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas [J].

Forsyth, PAJ ;

Petrov, E ;

Mahallati, H ;

Cairncross, JG ;

Brasher, P ;

MacRae, ME ;

Hagen, NA ;

Barnes, P ;

Sevick, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :2076-2081

[5]

Lang FF, 2002, NEURO-ONCOLOGY, V4, P268, DOI 10.1093/neuonc/4.4.268

[6] RESPONSE CRITERIA FOR PHASE-II STUDIES OF SUPRATENTORIAL MALIGNANT GLIOMA [J].

MACDONALD, DR ;

CASCINO, TL ;

SCHOLD, SC ;

CAIRNCROSS, JG .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1277-1280

[7] Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging [J].

Mardor, Y ;

Pfeffer, R ;

Spiegelmann, R ;

Roth, Y ;

Maier, SE ;

Nissim, O ;

Berger, R ;

Glicksman, A ;

Baram, J ;

Orenstein, A ;

Cohen, JS ;

Tichler, T .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :1094-1100

[8] Challenges in the design and conduct of phase III brain tumor therapy trials [J].

Perry, JR ;

DeAngelis, LM ;

Schold, SC ;

Burger, PC ;

Brem, H ;

Brown, MT ;

Curran, WJ ;

Scott, CB ;

Prados, MD ;

Kaplan, R ;

Cairncross, JG .

NEUROLOGY, 1997, 49 (04) :912-917

[9] Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma [J].

Vos, MJ ;

Hoekstra, OS ;

Barkhof, F ;

Berkhof, J ;

Heimans, JJ ;

van Groeningen, CJ ;

Vandertop, WP ;

Slotman, BJ ;

Postma, TJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3559-3565

[10] Interobserver variability in the radiological assessment of response to chemotherapy in glioma [J].

Vos, MJ ;

Uitdehaag, BMJ ;

Barkhof, F ;

Heimans, JJ ;

Baayen, HC ;

Boogerd, W ;

Castelijns, JA ;

Elkhuizen, PHM ;

Postma, TJ .

NEUROLOGY, 2003, 60 (05) :826-830

← 1 →